Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS • Currently down 27.30 (-58.47%) in today's trading session

Track congressional stock trades in Ultragenyx Pharmaceutical Inc. (RARE). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Ultragenyx Pharmaceutical Inc. is currently trading at $19.39, positioned at 5% of its 52-week range ($18.29 – $42.37). View which politicians have recently bought or sold RARE and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio in real-time with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$19.39
24h Change
-27.30 (-58.47%)
52 Week Range
$18.29—$42.37
View on NASDAQ

Ultragenyx Pharmaceutical Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for RARE

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.87B

Volume

2.33M

Beta

0.21

P/E Ratio

-3.33

Fundamentals

EPS

$-5.83

Div. Yield

—

Open

$19.40

Day Range

$19.13 — $19.77

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Emil D. Kakkis
IPO Date
2014-01-31
Website
www.ultragenyx.com

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and inte...

Earnings

Next Report

Q1 2026

5 May

EPS Est.

$-1.43

Rev. Est.

$164M

Days Until

36

Recent Quarters

Q4 202512 Feb
EPS$-1.29
Miss 7.5%
Q3 20254 Nov
EPS$-1.81
Miss 47.1%
Q2 20255 Aug
EPS$-1.17
Beat 7.9%
Q1 20256 May
EPS$-1.57
Miss 1.9%
Q4 202413 Feb
EPS$-1.39
Miss 5.3%
Q3 20245 Nov
EPS$-1.40
Beat 3.5%
Q2 20241 Aug
EPS$-1.52
Beat 7.3%
Q1 20242 May
EPS$-2.03
Miss 18.0%
Q4 202315 Feb
EPS$-1.52
Beat 7.9%
Q3 20232 Nov
EPS$-2.23
Miss 7.2%
Q2 20233 Aug
EPS$-2.25
Miss 6.6%
Q1 20234 May
EPS$-2.33
Miss 18.3%
Q4 202216 Feb
EPS$-2.16
Miss 6.4%
Q3 20222 Nov
EPS$-2.43
Miss 6.1%
Q2 202228 Jul
EPS$-2.26
Miss 31.4%
Q1 20225 May
EPS$-2.19
Miss 24.4%
Q4 202110 Feb
EPS$-1.79
Miss 35.6%
Q3 20212 Nov
EPS$-1.08
Beat 24.5%
Q2 20212 Aug
EPS$-1.45
Miss 13.3%
Q1 20214 May
EPS$-2.03
Miss 62.4%
Q4 202011 Feb
EPS$-1.34
Miss 26.4%
Q3 202027 Oct
EPS$-1.13
Beat 8.9%
Q2 202030 Jul
EPS$-0.82
Beat 47.4%
Q1 20206 May
EPS$-2.04
Miss 27.5%
Q4 201913 Feb
EPS$-1.64
Miss 1.9%
Q3 20195 Nov
EPS$-1.96
Miss 14.6%
Q2 20191 Aug
EPS$-1.72
Beat 0.6%
Q1 20196 May
EPS$-1.82
Miss 5.2%
Q4 201819 Feb
EPS$-1.73
Beat 0.6%
Q3 20185 Nov
EPS$-1.74
Beat 10.3%
Q2 20182 Aug
EPS$-1.87
Beat 10.9%
Q1 20187 May
EPS$0.62
Beat 203.3%
Q4 201720 Feb
EPS$-2.27
Miss 13.5%
Q3 20172 Nov
EPS$-1.87
Beat 0.0%
Q2 201727 Jul
EPS$-1.72
Beat 0.6%
Q1 20174 May
EPS$-1.63
Beat 4.1%
Q4 201616 Feb
EPS$-1.75
Miss 0.6%
Q3 20167 Nov
EPS$-1.64
Miss 7.2%
Q2 20168 Aug
EPS$-1.46
Beat 0.7%
Q1 20169 May
EPS$-1.35
Miss 4.7%
Q4 201525 Feb
EPS$-1.42
Miss 27.9%
Q3 20159 Nov
EPS$-1.03
Miss 21.2%
Q2 201513 Aug
EPS$-0.83
Miss 33.9%
Q1 201511 May
EPS$-0.63
Miss 16.7%
Q4 201425 Mar
EPS$-0.52
Beat 1.9%
Q3 201410 Nov
EPS$-0.50
Miss 11.1%
Q2 201411 Aug
EPS$-0.45
Miss 9.8%
Q1 201412 May
EPS$-0.85
Miss 123.7%
Q4 201324 Mar
EPS$-3.35
Q4 201324 Mar
EPS$-4.98
Miss 1210.5%
Q1 201330 Jun
EPS$-0.37
Q4 201231 Mar
EPS$-0.29
Q3 201231 Dec
EPS$-1.46

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi TrackerJoin our Discord
PoliticiansPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.